开发针对肝细胞癌的向治疗方法:对有前途的II期药物的批判性评估
Elisabeth Amadeo1, Silvia Foti1, Silvia Camera1
1Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Expert opinion on investigational drugs
|July 23, 2024
概括
肝细胞癌 (HCC) 治疗进展,使用铁激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI). 需要进一步的研究来优化分子测试和耐药性监测,以改善临床实践.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症相关死亡的主要原因.
- 氨酸激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI) 代表了HCC管理的重大治疗进展.
- 目前的研究重点是针对HCC治疗的新组合和替代途径目标.
研究的目的:
- 审查最近肝细胞癌 (HCC) 的治疗进展.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
- 强调需要在临床实践中扩大分子测试和耐药性监测的必要性.
主要方法:
- 审查最近的临床试验和实验室研究在HCC治疗.
- 分析氨酸激酶抑制剂 (TKI) 在单一治疗和组合治疗中的作用.
- 评估新兴的向疗法和免疫检查点抑制剂 (ICI).
主要成果:
- 氨酸激酶抑制剂 (TKI) 越来越多地成为HCC治疗方案的组成部分.
- 结合TKI与免疫检查点抑制剂 (ICI) 的结合显示出有前途.
- 第二阶段试验正在探索新的组合和替代突变目标.
结论:
- 氨酸激酶抑制剂 (TKI) 在当前的HCC治疗策略中发挥着关键作用.
- 扩大分子测试和获得耐药性的监测对于有效的HCC管理至关重要.
- 进一步的研究是必不可少的,以弥合实验室发现和临床实践在HCC治疗中的差距.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
726
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K